Publications by authors named "Alban Michaud-Herbst"
Article Synopsis
- Biological therapies like adalimumab, infliximab, and vedolizumab are commonly used to manage ulcerative colitis (UC), but many patients either don't respond or experience side effects.
- A study involving 134 patients assessed how well these treatments worked and how long patients continued using them, finding that response rates varied from 47.5% to 62.5% for the different drugs.
- Overall, 61.9% of patients reported adverse events, with over half staying on treatment for at least two years, highlighting both the effectiveness and challenges of these biologics.
Background And Aims: Drugs are considered a relatively rare and understudied cause of acute pancreatitis (AP). The lack of convincing and conclusive data on drug-induced AP (DIAP) complicates the diagnosis as well as the identification of the causative drug. The aim of this study is to document causes of DIAP cases that occurred in the Saguenay-Lac-Saint-Jean (SLSJ) population.
View Article and Find Full Text PDFBackground And Aims: Compliance with guidelines on colonoscopic indications can improve colorectal cancer screening efficiency. We conducted a regional practice survey of gastroenterologists working in the public and private sectors in France, and compared the results with French national guidelines.
Methods: Four consecutive yearly questionnaire-based practice surveys were conducted, and remedial measures were recommended on the basis of the results.